Literature DB >> 8557465

In vitro studies on the relative sensitivity to ivermectin of Necator americanus and Ancylostoma ceylanicum.

J C Richards1, J M Behnke, I R Duce.   

Abstract

Experiments were carried out to compare the sensitivity of Ancylostoma ceylanicum and Necator americanus to ivermectin (IVM) and pyrantel in vitro. Loss of motility and inhibition of ingestion by IVM were compared and A. ceylanicum was found to be approximately 40-50 times more sensitive to IVM than N. americanus. Both species showed a similar sensitivity to pyrantel. Uptake of [3H]IVM across the cuticle was compared and shown to be unlikely to account for the differences in sensitivity to IVM between the two species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557465     DOI: 10.1016/0020-7519(95)00036-2

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  14 in total

Review 1.  Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery.

Authors:  Richard J Martin; Alan P Robertson
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  A reappraisal of the relative sensitivity of nematode pharyngeal and somatic musculature to macrocyclic lactone drugs.

Authors:  Andrew C Kotze; Barney M Hines; Angela P Ruffell
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-10       Impact factor: 4.077

3.  Cyclotide interactions with the nematode external surface.

Authors:  Michelle L Colgrave; Yen-Hua Huang; David J Craik; Andrew C Kotze
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

4.  Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections.

Authors:  Janneke M Brussee; Anna Neodo; Jessica D Schulz; Jean T Coulibaly; Marc Pfister; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

5.  Ion channels and drug transporters as targets for anthelmintics.

Authors:  Robert M Greenberg
Journal:  Curr Clin Microbiol Rep       Date:  2014-12

6.  In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility.

Authors:  Rebecca S Treger; Joseph Otchere; Martin F Keil; Josephine E Quagraine; Ganesha Rai; Bryan T Mott; Debbie L Humphries; Michael Wilson; Michael Cappello; Jon J Vermeire
Journal:  Am J Trop Med Hyg       Date:  2013-12-02       Impact factor: 2.345

Review 7.  Is anthelmintic resistance a concern for the control of human soil-transmitted helminths?

Authors:  Jozef Vercruysse; Marco Albonico; Jerzy M Behnke; Andrew C Kotze; Roger K Prichard; James S McCarthy; Antonio Montresor; Bruno Levecke
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-10-14       Impact factor: 4.077

Review 8.  Ivermectin: An Anthelmintic, an Insecticide, and Much More.

Authors:  Richard J Martin; Alan P Robertson; Shivani Choudhary
Journal:  Trends Parasitol       Date:  2020-11-11

9.  Discrimination of gastrointestinal nematode eggs from crude fecal egg preparations by inhibitor-resistant conventional and real-time PCR.

Authors:  Janina Demeler; Sabrina Ramünke; Sonja Wolken; Davide Ianiello; Laura Rinaldi; Jean Bosco Gahutu; Giuseppe Cringoli; Georg von Samson-Himmelstjerna; Jürgen Krücken
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

10.  Genome of the human hookworm Necator americanus.

Authors:  Yat T Tang; Xin Gao; Bruce A Rosa; Sahar Abubucker; Kymberlie Hallsworth-Pepin; John Martin; Rahul Tyagi; Esley Heizer; Xu Zhang; Veena Bhonagiri-Palsikar; Patrick Minx; Wesley C Warren; Qi Wang; Bin Zhan; Peter J Hotez; Paul W Sternberg; Annette Dougall; Soraya Torres Gaze; Jason Mulvenna; Javier Sotillo; Shoba Ranganathan; Elida M Rabelo; Richard W Wilson; Philip L Felgner; Jeffrey Bethony; John M Hawdon; Robin B Gasser; Alex Loukas; Makedonka Mitreva
Journal:  Nat Genet       Date:  2014-01-19       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.